Pallas Capital Advisors LLC Increases Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Pallas Capital Advisors LLC lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 222.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 44,865 shares of the medical instruments supplier's stock after purchasing an additional 30,953 shares during the period. Pallas Capital Advisors LLC's holdings in DENTSPLY SIRONA were worth $670,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the company. Bank of New York Mellon Corp grew its stake in DENTSPLY SIRONA by 27.9% in the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock valued at $45,611,000 after buying an additional 523,692 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in DENTSPLY SIRONA by 1.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock valued at $39,880,000 after buying an additional 35,360 shares during the last quarter. Entropy Technologies LP bought a new stake in DENTSPLY SIRONA in the 4th quarter valued at about $630,000. First Eagle Investment Management LLC boosted its holdings in DENTSPLY SIRONA by 2.5% in the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock valued at $275,218,000 after purchasing an additional 348,532 shares during the period. Finally, Choreo LLC boosted its holdings in DENTSPLY SIRONA by 191.6% in the 4th quarter. Choreo LLC now owns 23,507 shares of the medical instruments supplier's stock valued at $440,000 after purchasing an additional 15,446 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY traded down $0.38 during trading on Friday, hitting $15.63. The company's stock had a trading volume of 1,408,937 shares, compared to its average volume of 2,971,156. The company has a 50-day moving average of $14.85 and a 200-day moving average of $16.82. DENTSPLY SIRONA Inc. has a 12 month low of $12.16 and a 12 month high of $27.95. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a market cap of $3.11 billion, a price-to-earnings ratio of -7.55, a P/E/G ratio of 1.80 and a beta of 0.95.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $879.00 million for the quarter, compared to analysts' expectations of $854.75 million. During the same quarter last year, the business earned $0.42 EPS. The firm's revenue was down 7.8% compared to the same quarter last year. On average, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Shareholders of record on Friday, June 27th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 4.09%. The ex-dividend date is Friday, June 27th. DENTSPLY SIRONA's payout ratio is -14.10%.

Wall Street Analysts Forecast Growth

XRAY has been the subject of several research reports. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Wall Street Zen upgraded shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. UBS Group decreased their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research report on Friday, May 9th. Robert W. Baird reduced their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, February 28th. Finally, Morgan Stanley lowered shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective on the stock. in a research note on Tuesday, April 15th. Eleven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $20.36.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.